From: Bone marrow-derived mesenchymal stem cells attenuate myocardial ischemia–reperfusion injury via upregulation of splenic regulatory T cells
Group
Infarction area \((\overline{x} \pm {\text{SD}},\% )\)
IgG
31.13 ± 6.82
IgG + BM-MSCs
20.15 ± 1.22
PC61
54.79 ± 7.65
PC61 + BM-MSCs
39.68 ± 4.12
Splenectomy
57.30 ± 11,091
Splenectomy + BM-MSCs
52.53 ± 8.55